GlassScriptPhysician profile
Steven M Siwek
NPI 1932204435
$56,707.84
in general payments reported to CMS, 2019-2025
47 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $2,960 · 2021: $5,111 · 2022: $4,418 · 2023: $2,649 · 2024: $40K · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $38K · Food and Beverage: $5,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $37,985.00 |
| Food and Beverage | $5,322.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $37,985.00 | 2024 | |
| Abbott Laboratories | $7,133.80 | 2019-2025 | Proclaim, Eterna, Octrode |
| Impactortho, INC. | $1,612.39 | 2020 | |
| Boston Scientific Corporation | $1,606.57 | 2019-2024 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Vertos Medical, INC. | $1,035.35 | 2021-2024 | Mild Device Kit |
| Nalu Medical, INC. | $927.74 | 2021-2024 | Nalu Neurostimulation System |
| Painteq LLC | $643.79 | 2021-2024 | Painteq |
| Relievant Medsystems, INC. | $589.96 | 2022 | |
| Abbvie INC. | $584.66 | 2021-2023 | Botox, Ubrelvy |
| Goode Surgical INC | $580.12 | 2020 | |
| Nevro Corp. | $575.31 | 2019-2021 | |
| Biotronik Nro, INC. | $381.14 | 2024-2025 | Prospera |
| Spinal Simplicity, LLC | $320.56 | 2020-2022 | |
| Nuvasive, INC. | $276.61 | 2021-2022 | |
| Medtronic USA, INC. | $272.36 | 2019 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Siwek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.